At the American College of Obstetricians & Gynecologists’ 2022 Annual Scientific and Clinical Meeting, Lyndsey Harper, MD, FACOG, IF, and Laurie Mintz, PhD, explained how ob-gyns can help women take charge of their sexual function and how to address internalized shame, medical contributors to sexual dysfunction, and suggestions when considering a treatment plan for your patients.
Harper is an ob-gyn at the Texas A&M College of Medicine, and founder and CEO of Rosy, an application for women to explore evidence-based resources for decreased sexual desire. Laurie Mintz, PhD, is a sex therapist and psychologist specializing in sexual intimacy and relationships.
Female sexual function is often overlooked. According to a 2018 study in Cureus, 44% of women experience some type of sexual problem—whether it be desire, arousal, orgasm, or pain. The important part, said Harper, is to help the patients that experience distress because of these issues, which was about 14%.
Approaching a sexual problem requires ob-gyns to consider multiple biological, psychological, and physical factors. Cultural factors include a lack of sexual education, which results in a false image of female pleasure; shame-based messages from family, schools, or religious views, including purity culture. Many women also experience negative socialization messages, like, “if it’s good enough for him, it’s good enough for me.” Many women also experience internalized sex-shaming.
Individual factors may also be hindering a patient’s ability to improve their sexual health. Those factors include body image—especially body-image self-consciousness during sex, pressure to “perform,” no emotional connection during sex, and general depression and anxiety. Of course, a history of sexual assault, trauma, and/or abuse are also hugely impactful.
Mintz discussed the PLISSIT model for approaching female sexual dysfunction: Permission, Limited information, Specific Suggestions, and Intensive Therapy are all tools ob-gyns can use. Giving patients permission to try new things during sex, sharing information about the nerve endings in the vulva and clitoris, and even suggesting the use of a store-bought lubricant are a few things ob-gyns can do. "Research shows that, in fact, 80-95% of sexual problems can be solved without therapy," Mintz said.
The language we use when discussing female sexual health is critical, Mintz said. "We are linguistically erasing female sexual function when we call entire genitals by the part that is more sexually useful to male partners than the women themselves," she said.
There are several medical factors that can impact a woman’s sexual dysfunction, including:
How can you determine if it is a medication side effect? For starters, patients on psychotropic medications may be impacted more than others. “Depression and sexual disfunction are frequently comorbid to one another,” said Harper. “SSRI users had overall better sexual function than those with untreated depression. The major prescriptions that can impact sexual function are citalopram, fluoxetine, paroxetine, sertraline, and venlafaxine.”
Oral contraceptives can affect sexual function negatively in some patients and LARCS generally come with fewer side effects, Harper noted.
“The last step is simply talking to them about lower sexual function as a tradeoff for not being able to get out of the bed in the morning,” Mintz said. “There is even data that shows that vibrator use (pulsing air wave tech—womanizer) increases sexual function in patients on SSRIs.”
When approaching a treatment plan, Harper and Mintz recommend a few simple steps:
“Get your tribe together,” Harper said. “Women deserve access to sexual health resources and we area the keepers of those resources.”
Reference
1. Harper L. Mintz L. Recharging Women's Sexual Health. Presented at: 2022 American College of Obstetrics and Gynecology Annual Clinical & Scientific Meeting; May 6 to May 8, 2022.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More